San Carlos, CA, United States of America

Lori Friedman

USPTO Granted Patents = 22 

 

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 85(Granted Patents)


Location History:

  • San Francisco, CA (US) (2004 - 2011)
  • South San Francisco, CA (US) (2012 - 2013)
  • San Carlos, CA (US) (2010 - 2018)

Company Filing History:


Years Active: 2004-2018

Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Innovations in Breast Cancer Treatment: The Contributions of Lori Friedman

Introduction

Lori Friedman, based in San Carlos, California, has made significant strides in the field of breast cancer treatment, holding an impressive portfolio of 22 patents. Her work primarily focuses on novel methodologies and compositions aimed at tackling various forms of breast cancer, particularly those resistant to traditional therapies.

Latest Patents

Friedman's latest patents include groundbreaking methods for treating positive receptor luminal A breast cancer using a PI3K inhibitor, pictilisib. This patent outlines methodologies and compositions designed to enhance the efficacy of breast cancer treatments by combining the PI3K inhibitor GDC-0941 with endocrine therapy agents. Additionally, she has developed methods for modulating estrogen receptor mutants, providing innovative strategies for treating conditions linked to mutations in the ESR1 gene. These methods focus on combating hormone-resistant ER-positive breast cancers through the use of estrogen receptor modulators.

Career Highlights

Throughout her career, Lori Friedman has worked with notable companies such as Exelixis, Inc. and Genentech, Inc., where she has contributed to the development of cutting-edge cancer therapies. Her expertise and innovative spirit have positioned her as a key figure in oncological research, enabling a deeper understanding of hormone-related cancers and resistance mechanisms.

Collaborations

Friedman's collaborative efforts with esteemed colleagues such as Helen Louise Francis-Lang and Marcia Belvin have further enriched her research contributions. These partnerships have fostered an environment of shared knowledge and innovation, allowing for a multidisciplinary approach to solving complex problems in breast cancer treatment.

Conclusion

Lori Friedman’s contributions to breast cancer research and treatment are evidenced by her numerous patents and collaborative efforts. As she continues to push the boundaries of medical science, her work serves as an inspiration for future innovations in the field of oncology, particularly for patients battling aggressive and resistant forms of breast cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…